These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 28718029)

  • 61. Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome.
    Gyamlani G; Molnar MZ; Lu JL; Sumida K; Kalantar-Zadeh K; Kovesdy CP
    Nephrol Dial Transplant; 2017 Jan; 32(1):157-164. PubMed ID: 28391310
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
    Larsen TB; Skjøth F; Kjældgaard JN; Lip GYH; Nielsen PB; Søgaard M
    Lancet Haematol; 2017 May; 4(5):e237-e244. PubMed ID: 28411120
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence.
    Kunutsor SK; Seidu S; Khunti K
    Ann Med; 2018 Sep; 50(6):529-537. PubMed ID: 30001640
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study.
    Van Schouwenburg IM; Mahmoodi BK; Veeger NJ; Bakker SJ; Kluin-Nelemans HC; Meijer K; Gansevoort RT
    J Thromb Haemost; 2012 Jun; 10(6):1012-8. PubMed ID: 22443091
    [TBL] [Abstract][Full Text] [Related]  

  • 65. D-dimer before chemotherapy might predict venous thromboembolism.
    Arpaia G; Carpenedo M; Verga M; Mastrogiacomo O; Fagnani D; Lanfredini M; Milani M; Cimminiello C
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):170-5. PubMed ID: 19276795
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increased risk of venous thromboembolism within the first year after Staphylococcus aureus bacteraemia: a nationwide observational matched cohort study.
    Mejer N; Westh H; Schønheyder HC; Jensen AG; Larsen AR; Skov R; Benfield T;
    J Intern Med; 2014 Apr; 275(4):387-97. PubMed ID: 24118528
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Platelet-Monocyte Aggregates and C-Reactive Protein are Associated with VTE in Older Surgical Patients.
    Shih L; Kaplan D; Kraiss LW; Casper TC; Pendleton RC; Peters CL; Supiano MA; Zimmerman GA; Weyrich AS; Rondina MT
    Sci Rep; 2016 Jun; 6():27478. PubMed ID: 27270163
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adipokines and incident venous thromboembolism: The Multi-Ethnic Study of Atherosclerosis.
    Broni EK; Ogunmoroti O; Quispe R; Sweeney T; Varma B; Fashanu OE; Lutsey PL; Matthew Allison ; Moyses Szklo ; Ndumele CE; Michos ED
    J Thromb Haemost; 2023 Feb; 21(2):303-310. PubMed ID: 36700499
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fasting plasma glucose, oral glucose tolerance test, and the risk of first-time venous thromboembolism. A report from the VEINS cohort study.
    Johansson M; Lind M; Jansson JH; Fhärm E; Johansson L
    Thromb Res; 2018 May; 165():86-94. PubMed ID: 29604434
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thyroid function, as assessed by TSH, and future risk of venous thromboembolism: the Tromsø study.
    Lerstad G; Enga KF; Jorde R; Brodin EE; Svartberg J; Brækkan SK; Hansen JB
    Eur J Endocrinol; 2015 Jul; 173(1):83-90. PubMed ID: 25899580
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Venous thromboembolism in patients with cholangiocarcinoma: focus on risk factors and impact on survival.
    Jeon HK; Kim DU; Baek DH; Ha DW; Lee BE; Ryu DY; Cheong JH; Kim GH; Song GA; Jang AL
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):444-9. PubMed ID: 22410715
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Incidence of and risk factors for venous thromboembolism during surgical treatment for esophageal cancer: a single-institution study.
    Kato F; Takeuchi H; Matsuda S; Kawakubo H; Omori T; Kitagawa Y
    Surg Today; 2016 Apr; 46(4):445-52. PubMed ID: 26094966
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High microRNA-145 plasma levels are associated with decreased risk of future incident venous thromboembolism: the HUNT study.
    Morelli VM; Snir O; Hindberg KD; Hveem K; Brækkan SK; Hansen JB
    Blood; 2024 Apr; 143(17):1773-1781. PubMed ID: 38211336
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study.
    Tagalakis V; Eberg M; Kahn S; Azoulay L
    Thromb Haemost; 2016 Jun; 115(6):1220-8. PubMed ID: 26819144
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Elevated hepatic enzymes and incidence of venous thromboembolism: a prospective study.
    Folsom AR; Lutsey PL; Roetker NS; Rosamond WD; Lazo M; Heckbert SR; Basu S; Cushman M; Selvin E
    Ann Epidemiol; 2014 Nov; 24(11):817-821.e2. PubMed ID: 25277506
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study.
    Di Minno MN; Dentali F; Lupoli R; Ageno W
    Circulation; 2014 Jan; 129(4):497-503. PubMed ID: 24146249
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Obesity in adolescent men increases the risk of venous thromboembolism in adult life.
    Glise Sandblad K; Jern S; Åberg M; Robertson J; Torén K; Lindgren M; Adiels M; Hansson PO; Rosengren A
    J Intern Med; 2020 Jun; 287(6):734-745. PubMed ID: 32338406
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomics.
    Jensen SB; Hindberg K; Solomon T; Smith EN; Lapek JD; Gonzalez DJ; Latysheva N; Frazer KA; Braekkan SK; Hansen JB
    J Thromb Haemost; 2018 Sep; 16(9):1763-1774. PubMed ID: 29964323
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Circulating Serum Magnesium and the Risk of Venous Thromboembolism in Men: A Long-Term Prospective Cohort Study.
    Kunutsor SK; Laukkanen JA
    Pulse (Basel); 2021 Jun; 8(3-4):108-113. PubMed ID: 34307207
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study.
    Puurunen MK; Hwang SJ; O'Donnell CJ; Tofler G; Johnson AD
    Thromb Res; 2017 Mar; 151():57-62. PubMed ID: 28152437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.